Nu Skin (NUS) Q4 Results in China Better than Feared; BTIG Maintains 'Neutral' Rating
Tweet Send to a Friend
BTIG maintains a Neutral stance on Nu Skin Enterprises (NYSE: NUS) following the company's Q4 results and Q1 outlook issued ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
